{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:59:44Z","timestamp":1787165984586,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd005435","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T00:00:00Z","timestamp":1145404800000}}],"reference-count":20,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005435.pub2","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T16:10:34Z","timestamp":1147191034000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis"],"prefix":"10.1002","volume":"2019","author":[{"given":"Abigail","family":"Fraser","sequence":"first","affiliation":[{"name":"University of Bristol, Oakfield House; Department of Social Medicine, MRC Centre for Causal Analysis in Translational Epidemiology; Oakfield Road Bristol UK BS8 2BN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Rabin Medical Center; Infectious Diseases Unit and Department of Medicine E; Beilinson Campus Petah-Tikva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Attamna","sequence":"additional","affiliation":[{"name":"Regional Tuberculosis Clinic; Botkovsky 25 Hadera Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"Beilinson Campus, Rabin Medical Center; Department of Medicine E; 39 Jabotinsky Street Petah-Tiqva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,19]]},"reference":[{"key":"10.1002\/14651858.CD005435.pub2-BIB0001|cit1","first-page":"221","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161 (4 Pt 2)","author":"American Thoracic Society","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"31","key":"10.1002\/14651858.CD005435.pub2-BIB0002|cit2","first-page":"735","article-title":"Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention (CDC)","year":"2003","journal-title":"MMWR"},{"issue":"7","key":"10.1002\/14651858.CD005435.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD005435.pub2-BIB0004|cit4","first-page":"19","article-title":"Chemoprophylaxis to prevent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review","volume":"1","author":"Fraser","year":"2006","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1002\/14651858.CD005435.pub2-BIB0005|cit5","unstructured":"Higgins J Green S Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions [updated March 2005]; Appendix 5b www.cochrane.org\/resources\/handbook\/hbook.htm"},{"issue":"3","key":"10.1002\/14651858.CD005435.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/499244","article-title":"Severe or fatal liver injury in 50 patients in the United States taking rifampbin and pyrazinamide for latent tuberculosis infection","volume":"42","author":"Ijaz","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"23","key":"10.1002\/14651858.CD005435.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","article-title":"Clinical practice. Latent tuberculosis infection","volume":"347","author":"Jasmer","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005435.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","author":"Kritski","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD005435.pub2-BIB0009|cit9","volume-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","author":"Mandell","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD005435.pub2-BIB0010|cit10","first-page":"489","article-title":"Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework","volume":"80","author":"Pablos-Mendez","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"10.1002\/14651858.CD005435.pub2-BIB0011|cit11","first-page":"131","article-title":"Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis","volume":"167","author":"Papastavros","year":"2002","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD005435.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1378\/chest.106.2.431","article-title":"Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey","volume":"106","author":"Passannante","year":"1994","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD005435.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00006454-199906000-00004","article-title":"Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases","volume":"8","author":"Schaaf","year":"1999","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD005435.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD005435.pub2-BIB0015|cit15","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005435.pub2-BIB0016|cit16","volume-title":"Anti-tuberculosis drug resistance in the world : third global report \/ the WHO\/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 1999-2002","author":"Stop TB","year":"2004"},{"key":"10.1002\/14651858.CD005435.pub2-BIB0017|cit17","unstructured":"The World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects www.wma.net\/e\/policy\/b3.htm"},{"issue":"1","key":"10.1002\/14651858.CD005435.pub2-BIB0018|cit18","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Woldehanna","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD005435.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005435.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005435","article-title":"Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis","author":"Fraser","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005435.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:17:39Z","timestamp":1769588259000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005435.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,4,19]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005435.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,19]]}}}